Skip to main content
Watch Insiders
CTNM filings

Corporate insider profile

Daniel S. Lorrain Filing Activity

Latest reported as Chief Scientific Officer of Contineum Therapeutics, Inc. (CTNM).

Purchase filings
0
Reported companies
1
Net open-market value
-$720,774.05
Latest transaction
Jul 9, 2026

Affiliated corporations

Reported company relationships

CTNMLatest reported

Contineum Therapeutics, Inc.

Chief Scientific Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jul 9, 2026Contineum Therapeutics, Inc. (CTNM)Chief Scientific OfficerSale1,040$16.00$16,640
Jul 1, 2026Contineum Therapeutics, Inc. (CTNM)Chief Scientific OfficerSale37,179$15.99$594,578
Jun 1, 2026Contineum Therapeutics, Inc. (CTNM)Chief Scientific OfficerSale4,170$13.16$54,862
🔒 Unlock Real-Time Alerts and 2 More High-Conviction Rows — Subscribe to Watch Insiders Premium